Vanguard Group’s Evoke Pharma EVOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $15.8K | Hold |
|
|||||
|
2024
Q1 | $18.2K | Hold |
|
|||||
|
2023
Q4 | $31.4K | Hold |
|
|||||
|
2023
Q3 | $41.2K | Hold |
|
|||||
|
2023
Q2 | $49.3K | Hold |
|
|||||
|
2023
Q1 | $56.7K | Hold |
|
|||||
|
2022
Q4 | $80K | Hold |
|
|||||
|
2022
Q3 | $56K | Sell |
|
|||||
|
2022
Q2 | $102K | Sell |
|
|||||
|
2022
Q1 | $553K | Sell |
|
|||||
|
2021
Q4 | $618K | Hold |
|
|||||
|
2021
Q3 | $1.46M | Buy |
|
|||||
|
2021
Q2 | $1.53M | Sell |
|
|||||
|
2021
Q1 | $2.08M | Buy |
|
|||||
|
2020
Q4 | $2.66M | Sell |
|
|||||
|
2020
Q3 | $4.85M | Buy |
|
|||||
|
2020
Q2 | $2.33M | Buy |
|
|||||
|
2020
Q1 | $560K | Hold |
|
|||||
|
2019
Q4 | $782K | Hold |
|
|||||
|
2019
Q3 | $415K | Buy |
|
|||||
|
2019
Q2 | $140K | Sell |
|
|||||
|
2019
Q1 | $954K | Buy |
|
|||||
|
2018
Q4 | $1.34M | Buy |
|
|||||
|
2018
Q3 | $1.6M | Hold |
|
|||||
|
2018
Q2 | $1.34M | Buy |
|
|||||
|
2018
Q1 | $1.05M | Sell |
|
|||||
|
2017
Q4 | $1.15M | Sell |
|
|||||
|
2017
Q3 | $1.75M | Hold |
|
|||||
|
2017
Q2 | $1.34M | Buy |
|
|||||
|
2017
Q1 | $1.41M | Buy |
|
|||||
|
2016
Q4 | $447K | Buy |
|
|||||
|
2016
Q3 | $482K | Buy |
|
|||||
|
2016
Q2 | $427K | Buy |
|
|||||
|
2016
Q1 | $302K | Buy |
|
|||||
|
2015
Q4 | $195K | Hold |
|
|||||
|
2015
Q3 | $175K | Buy |
|
|||||
|
2015
Q2 | $283K | Buy |
|
|||||
|
2015
Q1 | $360K | Buy |
|
|||||
|
2014
Q4 | $287K | Hold |
|
|||||
|
2014
Q3 | $267K | Buy |
|
|||||
|
2014
Q2 | $378K | Buy |
|
|||||
|
2014
Q1 | $395K | Buy |
|
|||||
|
2013
Q4 | $270K | Buy |
|